Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds
During three decades, an enormous number of studies have demonstrated the critical role of nitric oxide (NO) as a second messenger engaged in the activation of many systems including vascular smooth muscle relaxation. The underlying cellular mechanisms involved in vasodilatation are essentially due...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Associação Brasileira de Divulgação Científica
2011-09-01
|
| Series: | Brazilian Journal of Medical and Biological Research |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2011000900017&lng=en&tlng=en |
| _version_ | 1818933084789145600 |
|---|---|
| author | A.C. Pereira M. Paulo A.V. Araújo G.J. Rodrigues L.M. Bendhack |
| author_facet | A.C. Pereira M. Paulo A.V. Araújo G.J. Rodrigues L.M. Bendhack |
| author_sort | A.C. Pereira |
| collection | DOAJ |
| description | During three decades, an enormous number of studies have demonstrated the critical role of nitric oxide (NO) as a second messenger engaged in the activation of many systems including vascular smooth muscle relaxation. The underlying cellular mechanisms involved in vasodilatation are essentially due to soluble guanylyl-cyclase (sGC) modulation in the cytoplasm of vascular smooth cells. sGC activation culminates in cyclic GMP (cGMP) production, which in turn leads to protein kinase G (PKG) activation. NO binds to the sGC heme moiety, thereby activating this enzyme. Activation of the NO-sGC-cGMP-PKG pathway entails Ca2+ signaling reduction and vasodilatation. Endothelium dysfunction leads to decreased production or bioavailability of endogenous NO that could contribute to vascular diseases. Nitrosyl ruthenium complexes have been studied as a new class of NO donors with potential therapeutic use in order to supply the NO deficiency. In this context, this article shall provide a brief review of the effects exerted by the NO that is enzymatically produced via endothelial NO-synthase (eNOS) activation and by the NO released from NO donor compounds in the vascular smooth muscle cells on both conduit and resistance arteries, as well as veins. In addition, the involvement of the nitrite molecule as an endogenous NO reservoir engaged in vasodilatation will be described. |
| first_indexed | 2024-12-20T04:42:46Z |
| format | Article |
| id | doaj.art-92a40b1f67744e609839be6ac44c0312 |
| institution | Directory Open Access Journal |
| issn | 1414-431X |
| language | English |
| last_indexed | 2024-12-20T04:42:46Z |
| publishDate | 2011-09-01 |
| publisher | Associação Brasileira de Divulgação Científica |
| record_format | Article |
| series | Brazilian Journal of Medical and Biological Research |
| spelling | doaj.art-92a40b1f67744e609839be6ac44c03122022-12-21T19:53:04ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2011-09-0144994795710.1590/S0100-879X2011000900017S0100-879X2011000900017Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compoundsA.C. Pereira0M. Paulo1A.V. Araújo2G.J. Rodrigues3L.M. Bendhack4Universidade de São PauloUniversidade de São PauloUniversidade de São PauloUniversidade de São PauloUniversidade de São PauloDuring three decades, an enormous number of studies have demonstrated the critical role of nitric oxide (NO) as a second messenger engaged in the activation of many systems including vascular smooth muscle relaxation. The underlying cellular mechanisms involved in vasodilatation are essentially due to soluble guanylyl-cyclase (sGC) modulation in the cytoplasm of vascular smooth cells. sGC activation culminates in cyclic GMP (cGMP) production, which in turn leads to protein kinase G (PKG) activation. NO binds to the sGC heme moiety, thereby activating this enzyme. Activation of the NO-sGC-cGMP-PKG pathway entails Ca2+ signaling reduction and vasodilatation. Endothelium dysfunction leads to decreased production or bioavailability of endogenous NO that could contribute to vascular diseases. Nitrosyl ruthenium complexes have been studied as a new class of NO donors with potential therapeutic use in order to supply the NO deficiency. In this context, this article shall provide a brief review of the effects exerted by the NO that is enzymatically produced via endothelial NO-synthase (eNOS) activation and by the NO released from NO donor compounds in the vascular smooth muscle cells on both conduit and resistance arteries, as well as veins. In addition, the involvement of the nitrite molecule as an endogenous NO reservoir engaged in vasodilatation will be described.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2011000900017&lng=en&tlng=enNitric oxideVasodilatationRuthenium complexNO-synthaseResistance arteryConduit vessel |
| spellingShingle | A.C. Pereira M. Paulo A.V. Araújo G.J. Rodrigues L.M. Bendhack Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds Brazilian Journal of Medical and Biological Research Nitric oxide Vasodilatation Ruthenium complex NO-synthase Resistance artery Conduit vessel |
| title | Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds |
| title_full | Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds |
| title_fullStr | Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds |
| title_full_unstemmed | Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds |
| title_short | Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds |
| title_sort | nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds |
| topic | Nitric oxide Vasodilatation Ruthenium complex NO-synthase Resistance artery Conduit vessel |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2011000900017&lng=en&tlng=en |
| work_keys_str_mv | AT acpereira nitricoxidesynthesisandbiologicalfunctionsofnitricoxidereleasedfromrutheniumcompounds AT mpaulo nitricoxidesynthesisandbiologicalfunctionsofnitricoxidereleasedfromrutheniumcompounds AT avaraujo nitricoxidesynthesisandbiologicalfunctionsofnitricoxidereleasedfromrutheniumcompounds AT gjrodrigues nitricoxidesynthesisandbiologicalfunctionsofnitricoxidereleasedfromrutheniumcompounds AT lmbendhack nitricoxidesynthesisandbiologicalfunctionsofnitricoxidereleasedfromrutheniumcompounds |